Please try another search
Canntab Therapeutics Limited is a Canada-based phytopharmaceutical company. The Company is focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Its hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions. The Company’s operations comprise a single segment engaged in the medical marijuana business. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet. It holds a cannabis standard processing and sales for medical purposes license and a cannabis research license from health Canada.
Name | Age | Since | Title |
---|---|---|---|
Eric Hatashita | - | - | Member of Advisory Board |
Richard C. Goldstein | 61 | 2018 | Interim CEO, Co-Founder, CFO & Director |
Sabrina Ramkellawan | - | - | Member of Advisory Board |
Barry M. Polisuk | 62 | 2018 | Secretary & Independent Director |
Hugh Hamish Sutherland | 64 | - | Member of Advisory Board |
Lorne Michael Gertner | 67 | - | Member of Advisory Board |
Vitor M. Fonseca | 69 | 2018 | Independent Director |
Bob Woloschuk | - | 2018 | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review